Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Indaptus Therapeutics Inc INDP

Healthcare Biotechnology
Indaptus Therapeutics, Inc. is a clinical-stage biotechnology company, which specializes in cancer and viral infection treatments. The Company’s approach is based on the hypothesis that activation of both innate and adaptive immune cells and pathways and associated anti-tumor and anti-viral immune responses will require a multi-targeted package of immune system-activating signals that can be... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:INDP)

Indaptus Therapeutics Presents Positive Mechanism of Action Data at the American Association for Cancer Research Annual Meeting

GlobeNewswire 9 days ago

Indaptus Therapeutics to Present at the MedInvest Biotech and Pharma Investor Conference

GlobeNewswire March 28, 2024

Indaptus Therapeutics Previews Positive Mechanism of Action Data to be Presented at the American Association for Cancer Research Annual Meeting

GlobeNewswire March 25, 2024

Indaptus Therapeutics to Participate in Tribe Public Webinar On Wednesday, March 20, 2024

GlobeNewswire March 18, 2024

Indaptus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update

GlobeNewswire March 13, 2024

Indaptus Therapeutics Announces Positive Results from Second Cohort of Phase 1 Trial; Company Initiates Multi-Dose Cohort

GlobeNewswire March 4, 2024

Indaptus Therapeutics to Present at the 2024 BIO CEO & Investor Conference

GlobeNewswire February 15, 2024

Indaptus Therapeutics Expands Digital Presence with Launch of Social Media Channels

GlobeNewswire February 8, 2024

European Patent Office Approves Key Patent for Indaptus Therapeutics' Platform Technology

GlobeNewswire January 4, 2024
View More News ››

Opinion & Analysis (NDAQ:INDP)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:INDP)

Indaptus Therapeutics Presents Positive Mechanism of Action

BREAKING NEWS: $INDP Indaptus Therapeutics Presents Positive Mechanism of Action Data at the American Association for Cancer Research...
whytestocks - 8 days ago

Indaptus Therapeutics Announces Positive Results from Second

Just In: $INDP Indaptus Therapeutics Announces Positive Results from Second Cohort of Phase 1 Trial; Company Initiates Multi-Dose Cohort...
whytestocks - March 4, 2024

A shorters wet dream paradise

A real POFS!!
MoMoneyNow - October 22, 2021

INDP ..... Now in PB mode

Got up to almost H.O.D.....now sub $12.75 Has to hold yesterdays opening low of $11.68 Me ...no position  Cheers !
Iseneschal - September 16, 2021

INDP ..... Moving over $14 now

All those chasers yesterday want their money back and The Shorters are covering pronto... JMHO $17 target.... JMHO  Cheers!
Iseneschal - September 16, 2021

INDP ...... huge runner yesterday

all the way from ~$6 to ~$30 and closed around $10 Up today and trading volume....anything is possible  Cheers !
Iseneschal - September 16, 2021
View more Bullboard ››

Africa Oil Corp.

Africa Oil Corp.

Africa Oil Corp. is a Canadian oil and gas company with producing and development assets in deepwater Nigeria and an ...
View More »